Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22-Reference-Cited by-同舟云学术

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22

Published:2018-12 Issue: Volume:11 Page:127-137
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Qin Haiying,Ramakrishna Sneha,Nguyen Sang,Fountaine Thomas J.,Ponduri Anusha,Stetler-Stevenson Maryalice,Yuan Constance M.,Haso Waleed,Shern Jack F.,Shah Nirali N.,Fry Terry J.

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference24 articles.

1. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

4. Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein;Qin;Blood,2015

5. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

2. Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer;British Journal of Pharmacology;2024-08-11

3. CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma;Nature Communications;2024-07-23

4. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells;Cellular Oncology;2024-07-15

5. Augmenting the landscape of chimeric antigen receptor T-cell therapy;Expert Review of Anticancer Therapy;2024-06-26